{"id":9660,"date":"2026-03-18T06:14:17","date_gmt":"2026-03-17T22:14:17","guid":{"rendered":"https:\/\/regask.com\/?p=9660"},"modified":"2026-03-18T06:14:17","modified_gmt":"2026-03-17T22:14:17","slug":"el-proveedor-de-servicios-de-internet-de-chile-introduce-un-marco-regulatorio-de-confianza-para-las-inspecciones-de-buenas-practicas-de-fabricacion-farmaceutica","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\/","title":{"rendered":"Proveedor de servicios de Internet chileno introduce marco regulatorio de confianza para\u2026"},"content":{"rendered":"<p><span data-contrast=\"auto\">En\u00a0<\/span><b><span data-contrast=\"auto\">9 de marzo de 2026<\/span><\/b><span data-contrast=\"auto\">, el\u00a0<\/span><b><span data-contrast=\"auto\">Instituto de Salud P\u00fablica de Chile (ISP)<\/span><\/b><span data-contrast=\"auto\">\u00a0public\u00f3 una resoluci\u00f3n que introduce directrices sobre\u00a0<\/span><b><span data-contrast=\"auto\">Mecanismos de confianza regulatoria para las inspecciones farmac\u00e9uticas<\/span><\/b><span data-contrast=\"auto\">. La resoluci\u00f3n, que entr\u00f3 en vigor el\u00a0<\/span><b><span data-contrast=\"auto\">28 de enero de 2026<\/span><\/b><span data-contrast=\"auto\">, establece un marco que permite a los reguladores chilenos basarse en los resultados de las inspecciones de autoridades internacionales confiables al evaluar\u00a0<\/span><b><span data-contrast=\"auto\">Buenas pr\u00e1cticas de fabricaci\u00f3n (BPF)<\/span><\/b><span data-contrast=\"auto\">\u00a0cumplimiento.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">La actualizaci\u00f3n se aplica a ambos\u00a0<\/span><b><span data-contrast=\"auto\">productos farmac\u00e9uticos nacionales e importados<\/span><\/b><span data-contrast=\"auto\">\u00a0y afecta\u00a0<\/span><b><span data-contrast=\"auto\">fabricantes, titulares de autorizaciones de comercializaci\u00f3n y organizaciones involucradas en la producci\u00f3n, distribuci\u00f3n y almacenamiento<\/span><\/b><span data-contrast=\"auto\">.El objetivo es reforzar la supervisi\u00f3n de las buenas pr\u00e1cticas farmac\u00e9uticas, al tiempo que se mejora la eficiencia de los procesos de inspecci\u00f3n.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<div class=\"row\"  id=\"row-1970970993\">\n\n\t<div id=\"col-707618003\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-818172484\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-818172484 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>Detalles de la actualizaci\u00f3n<\/h2>\n\t<div id=\"gap-1322040432\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1322040432 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">Conforme a las nuevas directrices, el ISP introduce un mecanismo de confianza estructurado que permite que los informes de inspecci\u00f3n emitidos por autoridades internacionales reconocidas sirvan de apoyo a la verificaci\u00f3n regulatoria en Chile.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Informes de inspecci\u00f3n de agencias reconocidas por\u00a0<\/span><b><span data-contrast=\"auto\">OPS\/OMS o el Esquema de Cooperaci\u00f3n en Inspecci\u00f3n Farmac\u00e9utica (PIC\/S)<\/span><\/b><span data-contrast=\"auto\">\u00a0Las autoridades chilenas podr\u00e1n utilizarlo para verificar\u00a0<\/span><b><span data-contrast=\"auto\">Cumplimiento de las Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF) para fabricantes farmac\u00e9uticos extranjeros<\/span><\/b><span data-contrast=\"auto\">. Estos informes pueden servir de apoyo a las evaluaciones reglamentarias relacionadas con las condiciones de fabricaci\u00f3n y los sistemas de calidad.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">La gu\u00eda tambi\u00e9n introduce\u00a0<\/span><b><span data-contrast=\"auto\">monitoreo basado en riesgos<\/span><\/b><span data-contrast=\"auto\">\u00a0informados por los hallazgos de las inspecciones regulatorias extranjeras. Estos hallazgos pueden influir en las decisiones regulatorias que afectan\u00a0<\/span><b><span data-contrast=\"auto\">productos farmac\u00e9uticos importados y sus titulares de registro<\/span><\/b><span data-contrast=\"auto\">, incluyendo actividades de verificaci\u00f3n y supervisi\u00f3n del cumplimiento.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Adem\u00e1s, el mecanismo respalda la\u00a0<\/span><b><span data-contrast=\"auto\">Priorizaci\u00f3n anual de las inspecciones de plantas de fabricaci\u00f3n extranjeras<\/span><\/b><span data-contrast=\"auto\">\u00a0asociado con productos farmac\u00e9uticos que ingresan al mercado chileno. Al utilizar los resultados de las inspecciones de reguladores internacionales confiables, el ISP busca asignar los recursos de inspecci\u00f3n de manera m\u00e1s eficiente, manteniendo los est\u00e1ndares de garant\u00eda de calidad.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Para respaldar este marco, las partes interesadas deben garantizar que\u00a0<\/span><b><span data-contrast=\"auto\">documentaci\u00f3n de inspecci\u00f3n emitida por autoridades reguladoras reconocidas<\/span><\/b><span data-contrast=\"auto\">\u00a0Est\u00e1 disponible para su revisi\u00f3n cuando lo solicite el regulador chileno. Esta documentaci\u00f3n puede ser requerida durante las evaluaciones regulatorias o las verificaciones de cumplimiento.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">En general, la gu\u00eda promueve\u00a0<\/span><b><span data-contrast=\"auto\">est\u00e1ndares de calidad armonizados entre los proveedores farmac\u00e9uticos nacionales e internacionales<\/span><\/b><span data-contrast=\"auto\">\u00a0operando bajo la supervisi\u00f3n regulatoria de Chile.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-707618003 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1512326511\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Fecha de entrada en vigor<\/h2>\n\t<div id=\"gap-1661833017\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1661833017 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW148914550 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW148914550 BCX0\">La resoluci\u00f3n\u00a0<\/span><span class=\"NormalTextRun SCXW148914550 BCX0\">estableciendo<\/span><span class=\"NormalTextRun SCXW148914550 BCX0\">\u00a0mecanismos de dependencia regulatoria para el\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW148914550 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW148914550 BCX0\">Subdepartamento de Inspecciones de la Agencia Nacional de Medicamentos <\/span><\/span><\/strong><span class=\"TextRun SCXW148914550 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW148914550 BCX0\">entr\u00f3 en vigor el <\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW148914550 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW148914550 BCX0\">28 de enero de 2026<\/span><\/span><span class=\"TextRun SCXW148914550 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW148914550 BCX0\">.<\/span><\/span><\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1512326511 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1362951419\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Por qu\u00e9 es importante<\/h2>\n\t<div id=\"gap-365792551\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-365792551 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>La introducci\u00f3n de mecanismos de confianza regulatoria respalda<strong> Armonizaci\u00f3n normativa y eficiencia en las inspecciones farmac\u00e9uticas.<\/strong> Al reconocer los hallazgos de inspecci\u00f3n de reguladores internacionales confiables, el ISP puede mejorar <strong>monitoreo basado en riesgos,<\/strong> reducir las actividades de inspecci\u00f3n duplicadas y mantener la supervisi\u00f3n de <strong>Cumplimiento de las Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF)<\/strong> para productos que ingresan al mercado chileno, minimizando la carga administrativa.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1362951419 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-237374223\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Para qui\u00e9n es relevante<\/h2>\n\t<div id=\"gap-408822175\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-408822175 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Esta actualizaci\u00f3n es relevante para <strong>fabricantes farmac\u00e9uticos, titulares de autorizaciones de comercializaci\u00f3n, equipos de asuntos regulatorios, profesionales de garant\u00eda de calidad y partes interesadas de la cadena de suministro<\/strong> involucrada en la producci\u00f3n, importaci\u00f3n, distribuci\u00f3n y almacenamiento de productos medicinales destinados al mercado chileno.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-237374223 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1853119187\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Pr\u00f3ximos pasos<\/h2>\n\t<div id=\"gap-1102043007\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1102043007 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span data-contrast=\"auto\">Las partes interesadas deber\u00edan\u00a0<\/span><b><span data-contrast=\"auto\">evaluar la preparaci\u00f3n actual para las inspecciones y los procedimientos de cumplimiento interno<\/span><\/b><span data-contrast=\"auto\">\u00a0para garantizar la alineaci\u00f3n con los mecanismos de confianza recientemente establecidos. Las organizaciones tambi\u00e9n deben verificar que\u00a0<\/span><b><span data-contrast=\"auto\">informes de inspecci\u00f3n y documentaci\u00f3n justificativa de autoridades internacionales reconocidas<\/span><\/b><span data-contrast=\"auto\">\u00a0Est\u00e1n disponibles para su revisi\u00f3n regulatoria si se solicitan.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">Se anima a las empresas a revisar la resoluci\u00f3n completa emitida por la\u00a0<\/span><b><span data-contrast=\"auto\">Instituto de Salud P\u00fablica de Chile (ISP)<\/span><\/b><span data-contrast=\"auto\">\u00a0comprender las expectativas detalladas relacionadas con la documentaci\u00f3n y la supervisi\u00f3n de las inspecciones.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">A medida que las autoridades reguladoras adoptan cada vez m\u00e1s mecanismos de confianza y marcos de cooperaci\u00f3n internacional, mantener la visibilidad en\u00a0<\/span><b><span data-contrast=\"auto\">Resultados de las inspecciones y requisitos de cumplimiento transfronterizo<\/span><\/b><span data-contrast=\"auto\">\u00a0se vuelve fundamental para las operaciones farmac\u00e9uticas globales.<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/es\/\"><strong>RegASK<\/strong><\/a>\u00a0es un l\u00edder\u00a0<\/span><b><span data-contrast=\"auto\">Plataforma de inteligencia regulatoria y orquestaci\u00f3n de flujos de trabajo con inteligencia artificial de Agentic<\/span><\/b><span data-contrast=\"auto\">\u00a0que permite a las organizaciones globales en sectores altamente regulados, incluidos productos de consumo y ciencias biol\u00f3gicas, navegar de manera proactiva en panoramas regulatorios complejos. <strong>Al combinar la IA avanzada de Agentic con expertos en el sector,\u00a0<a href=\"http:\/\/regask.com\/es\/\">RegASK<\/a>\u00a0<\/strong>Ofrece informaci\u00f3n predictiva y pr\u00e1ctica en tiempo real, as\u00ed como automatizaci\u00f3n integral, lo que agiliza los procesos de cumplimiento, mitiga los riesgos y acelera el acceso al mercado en m\u00e1s de 160 pa\u00edses.\u00a0<\/span><b><span data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/es\/\">M\u00e1s informaci\u00f3n<\/a> o <a href=\"https:\/\/regask.com\/es\/reservar-una-demostracion\/\">Reserve una demostraci\u00f3n ahora.<\/a><\/span><\/b><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1853119187 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-133754458\">\n\n\t<div id=\"col-10219530\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<div class=\"is-divider divider clearfix\" style=\"margin-top:2em;margin-bottom:2em;max-width:20%;height:1px;background-color:#a5acd9;\"><\/div>\n<h3>Preguntas frecuentes<\/h3>\n\t<div id=\"gap-72384847\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-72384847 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><span class=\"TextRun MacChromeBold SCXW192215078 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW192215078 BCX0\" data-ccp-parastyle=\"heading 3\">\u00bfQu\u00e9 cambios normativos introdujo el ISP de Chile en materia de inspecciones farmac\u00e9uticas?<\/span><\/span><span class=\"EOP SCXW192215078 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-499411730\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-499411730 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>El<strong> Instituto de Salud P\u00fablica de Chile (ISP)<\/strong> introdujo directrices que establecen <strong>mecanismos de dependencia regulatoria,<\/strong> permitir que las autoridades chilenas utilicen los resultados de las inspecciones de reguladores internacionales reconocidos para respaldar la supervisi\u00f3n de <strong>Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF). <\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-10219530 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1663835979\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW186654781 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW186654781 BCX0\" data-ccp-parastyle=\"heading 3\">\u00bfQu\u00e9 autoridades de inspecci\u00f3n internacionales est\u00e1n reconocidas seg\u00fan esta gu\u00eda?<\/span><\/span><span class=\"EOP SCXW186654781 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-854248172\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-854248172 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW72249622 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW72249622 BCX0\">Informes de inspecci\u00f3n de agencias enumeradas por\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW72249622 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW72249622 BCX0\">OPS\/OMS<\/span><\/span><\/strong><span class=\"TextRun SCXW72249622 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW72249622 BCX0\">\u00a0o miembros de la\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW72249622 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW72249622 BCX0\">Esquema de Cooperaci\u00f3n para la Inspecci\u00f3n Farmac\u00e9utica (PIC\/S)<\/span><\/span><\/strong><span class=\"TextRun SCXW72249622 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW72249622 BCX0\"><strong>\u00a0<\/strong>Puede utilizarse para respaldar la verificaci\u00f3n del cumplimiento de las Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF) para fabricantes farmac\u00e9uticos extranjeros.<\/span><\/span><span class=\"EOP SCXW72249622 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1663835979 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1678626123\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW114474107 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW114474107 BCX0\" data-ccp-parastyle=\"heading 3\">\u00bfA qui\u00e9n afecta el nuevo marco regulatorio de confianza en Chile?<\/span><\/span><span class=\"EOP SCXW114474107 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-1732610348\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1732610348 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW268415581 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW268415581 BCX0\">La gu\u00eda afecta\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW268415581 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW268415581 BCX0\">Fabricantes farmac\u00e9uticos, titulares de autorizaciones de comercializaci\u00f3n y organizaciones involucradas en la producci\u00f3n, distribuci\u00f3n y almacenamiento de medicamentos.<\/span><\/span><\/strong><span class=\"TextRun SCXW268415581 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW268415581 BCX0\"><strong>\u00a0<\/strong>Suministrado al mercado chileno.<\/span><\/span><span class=\"EOP SCXW268415581 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1678626123 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1939741361\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4><span class=\"TextRun MacChromeBold SCXW82391252 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW82391252 BCX0\" data-ccp-parastyle=\"heading 3\">\u00bfC\u00f3mo puedo?\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW82391252 BCX0\" data-ccp-parastyle=\"heading 3\">RegASK<\/span><span class=\"NormalTextRun SCXW82391252 BCX0\" data-ccp-parastyle=\"heading 3\">\u00a0\u00bfC\u00f3mo ayudar a las empresas a adaptarse a los marcos cambiantes de inspecci\u00f3n y regulaci\u00f3n?<\/span><\/span><span class=\"EOP SCXW82391252 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-1359072641\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1359072641 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW85818566 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><a href=\"http:\/\/regask.com\/es\/\"><strong><span class=\"NormalTextRun SpellingErrorV2Themed SCXW85818566 BCX0\">RegASK<\/span><\/strong><\/a><span class=\"NormalTextRun SCXW85818566 BCX0\">\u00a0ayuda a las organizaciones\u00a0<\/span><span class=\"NormalTextRun SCXW85818566 BCX0\">monitor<\/span><span class=\"NormalTextRun SCXW85818566 BCX0\">\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW85818566 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW85818566 BCX0\">Actualizaciones regulatorias globales, marcos de inspecci\u00f3n y requisitos de cumplimiento<\/span><\/span><\/strong><span class=\"TextRun SCXW85818566 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW85818566 BCX0\">\u00a0en m\u00faltiples\u00a0<\/span><span class=\"NormalTextRun SCXW85818566 BCX0\">jurisdicciones<\/span><span class=\"NormalTextRun SCXW85818566 BCX0\">. A trav\u00e9s de\u00a0<\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW85818566 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW85818566 BCX0\">Inteligencia regulatoria impulsada por IA y automatizaci\u00f3n de flujos de trabajo<\/span><\/span><\/strong><span class=\"TextRun SCXW85818566 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW85818566 BCX0\"><strong>,<\/strong> La plataforma ayuda a los equipos de regulaci\u00f3n y calidad a mantenerse alineados con los mecanismos de supervisi\u00f3n en constante evoluci\u00f3n, como las iniciativas de confianza regulatoria.<\/span><\/span><span class=\"EOP SCXW85818566 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1939741361 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>On\u00a0March 9, 2026, the\u00a0Institute of Public Health of Chile (ISP)\u00a0published a resolution introducing guidance on\u00a0regulatory reliance mechanisms for pharmaceutical inspections. The resolution, which became effective on\u00a0January 28, 2026,\u00a0establishes\u00a0a framework allowing Chilean regulators to rely on inspection findings from trusted international authorities when assessing\u00a0Good Manufacturing Practices (GMP)\u00a0compliance.\u00a0 The update applies to both\u00a0domestic and imported pharmaceutical products\u00a0and&#8230;<\/p>","protected":false},"author":43,"featured_media":9661,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33,564,35],"tags":[],"class_list":["post-9660","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-chile-regulations","category-pharma-biotech-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.8 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Chile ISP Introduces Regulatory Reliance Framework<\/title>\n<meta name=\"description\" content=\"Learn about the Chile ISP&#039;s new regulatory reliance framework for pharmaceutical GMP inspections enhancing efficiency and compliance.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/el-proveedor-de-servicios-de-internet-de-chile-introduce-un-marco-regulatorio-de-confianza-para-las-inspecciones-de-buenas-practicas-de-fabricacion-farmaceutica\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Chile ISP Introduces Regulatory Reliance Framework for Pharmaceutical GMP Inspections\" \/>\n<meta property=\"og:description\" content=\"Learn about the Chile ISP&#039;s new regulatory reliance framework for pharmaceutical GMP inspections enhancing efficiency and compliance.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/el-proveedor-de-servicios-de-internet-de-chile-introduce-un-marco-regulatorio-de-confianza-para-las-inspecciones-de-buenas-practicas-de-fabricacion-farmaceutica\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-17T22:14:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/chile-isp-introduces-regulatory-reliance-framework-pharmaceutical-gmp-inspections-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Reva Ananda\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Reva Ananda\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\\\/\"},\"author\":{\"name\":\"Reva Ananda\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\"},\"headline\":\"Chile ISP Introduces Regulatory Reliance Framework for &hellip;\",\"datePublished\":\"2026-03-17T22:14:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\\\/\"},\"wordCount\":927,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/chile-isp-introduces-regulatory-reliance-framework-pharmaceutical-gmp-inspections-1.png\",\"articleSection\":[\"Regulatory News\",\"Chile\",\"Pharma and Biotech\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\\\/\",\"name\":\"Chile ISP Introduces Regulatory Reliance Framework\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/chile-isp-introduces-regulatory-reliance-framework-pharmaceutical-gmp-inspections-1.png\",\"datePublished\":\"2026-03-17T22:14:17+00:00\",\"description\":\"Learn about the Chile ISP's new regulatory reliance framework for pharmaceutical GMP inspections enhancing efficiency and compliance.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/chile-isp-introduces-regulatory-reliance-framework-pharmaceutical-gmp-inspections-1.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/chile-isp-introduces-regulatory-reliance-framework-pharmaceutical-gmp-inspections-1.png\",\"width\":800,\"height\":600,\"caption\":\"Chile Isp Introduces Regulatory Reliance Framework Pharmaceutical Gmp Inspections\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/4023a3aab44f61a84d06ca8abfcbe926\",\"name\":\"Reva Ananda\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Proveedor de servicios de Internet chileno introduce marco regulatorio de confianza","description":"Conozca el nuevo marco regulatorio del ISP de Chile para las inspecciones de Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF) farmac\u00e9uticas, que mejora la eficiencia y el cumplimiento.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/el-proveedor-de-servicios-de-internet-de-chile-introduce-un-marco-regulatorio-de-confianza-para-las-inspecciones-de-buenas-practicas-de-fabricacion-farmaceutica\/","og_locale":"es_ES","og_type":"article","og_title":"Chile ISP Introduces Regulatory Reliance Framework for Pharmaceutical GMP Inspections","og_description":"Learn about the Chile ISP's new regulatory reliance framework for pharmaceutical GMP inspections enhancing efficiency and compliance.","og_url":"https:\/\/regask.com\/es\/el-proveedor-de-servicios-de-internet-de-chile-introduce-un-marco-regulatorio-de-confianza-para-las-inspecciones-de-buenas-practicas-de-fabricacion-farmaceutica\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-03-17T22:14:17+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/chile-isp-introduces-regulatory-reliance-framework-pharmaceutical-gmp-inspections-1.png","type":"image\/png"}],"author":"Reva Ananda","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Reva Ananda","Est. reading time":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\/#article","isPartOf":{"@id":"https:\/\/regask.com\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\/"},"author":{"name":"Reva Ananda","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926"},"headline":"Chile ISP Introduces Regulatory Reliance Framework for &hellip;","datePublished":"2026-03-17T22:14:17+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\/"},"wordCount":927,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/chile-isp-introduces-regulatory-reliance-framework-pharmaceutical-gmp-inspections-1.png","articleSection":["Regulatory News","Chile","Pharma and Biotech"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\/","url":"https:\/\/regask.com\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\/","name":"Proveedor de servicios de Internet chileno introduce marco regulatorio de confianza","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/chile-isp-introduces-regulatory-reliance-framework-pharmaceutical-gmp-inspections-1.png","datePublished":"2026-03-17T22:14:17+00:00","description":"Conozca el nuevo marco regulatorio del ISP de Chile para las inspecciones de Buenas Pr\u00e1cticas de Fabricaci\u00f3n (BPF) farmac\u00e9uticas, que mejora la eficiencia y el cumplimiento.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/chile-isp-introduces-regulatory-reliance-framework-for-pharmaceutical-gmp-inspections\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/chile-isp-introduces-regulatory-reliance-framework-pharmaceutical-gmp-inspections-1.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/03\/chile-isp-introduces-regulatory-reliance-framework-pharmaceutical-gmp-inspections-1.png","width":800,"height":600,"caption":"Chile Isp Introduces Regulatory Reliance Framework Pharmaceutical Gmp Inspections"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"El sistema operativo de IA regulatoria para equipos de alto rendimiento","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/4023a3aab44f61a84d06ca8abfcbe926","name":"Reva Ananda"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/9660","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/43"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=9660"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/9660\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/9661"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=9660"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=9660"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=9660"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}